ArTS Archivio della ricerca di Trieste

TOFFOLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.058
EU - Europa 2.947
AS - Asia 2.466
SA - Sud America 352
AF - Africa 125
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.963
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.952
SG - Singapore 847
PL - Polonia 843
IT - Italia 595
CN - Cina 510
VN - Vietnam 357
DE - Germania 276
BR - Brasile 269
SE - Svezia 266
HK - Hong Kong 222
FR - Francia 168
FI - Finlandia 134
GB - Regno Unito 125
KR - Corea 108
NL - Olanda 102
RU - Federazione Russa 99
IN - India 94
CA - Canada 64
UA - Ucraina 63
BG - Bulgaria 58
IE - Irlanda 51
JP - Giappone 51
TR - Turchia 44
MA - Marocco 42
PK - Pakistan 35
ZA - Sudafrica 27
IR - Iran 26
MX - Messico 26
AR - Argentina 25
BD - Bangladesh 25
BE - Belgio 23
ES - Italia 23
AT - Austria 20
CH - Svizzera 20
IQ - Iraq 20
SN - Senegal 19
ID - Indonesia 15
PH - Filippine 15
VE - Venezuela 15
AU - Australia 14
EC - Ecuador 13
CZ - Repubblica Ceca 11
RO - Romania 11
LB - Libano 10
SA - Arabia Saudita 10
EG - Egitto 9
PT - Portogallo 9
CL - Cile 8
CO - Colombia 8
DK - Danimarca 8
JO - Giordania 8
TH - Thailandia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
MY - Malesia 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
TW - Taiwan 6
BO - Bolivia 5
HU - Ungheria 5
KZ - Kazakistan 5
PY - Paraguay 5
RS - Serbia 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
GR - Grecia 4
LK - Sri Lanka 4
LT - Lituania 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
AZ - Azerbaigian 3
ET - Etiopia 3
HR - Croazia 3
KE - Kenya 3
NP - Nepal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BZ - Belize 2
CG - Congo 2
IL - Israele 2
LU - Lussemburgo 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
QA - Qatar 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
Totale 9.949
Salva come PNG Salva come JPEG
Città #
Warsaw 794
Ashburn 536
Singapore 528
Chandler 357
Fairfield 295
San Jose 236
Hong Kong 201
Woodbridge 200
Trieste 192
Houston 163
Dallas 155
Munich 152
Ann Arbor 146
Seattle 141
Wilmington 125
Cambridge 109
Beijing 103
Seoul 99
Ho Chi Minh City 97
Los Angeles 92
Helsinki 91
Hanoi 78
Princeton 76
Jacksonville 65
Council Bluffs 63
Hefei 61
Boardman 60
Sofia 58
Chicago 57
Lauterbourg 53
Santa Clara 48
Columbus 46
Dublin 46
Frankfurt am Main 41
The Dalles 39
Moscow 38
Redmond 37
Zgierz 37
Tokyo 34
Casablanca 32
London 31
Rome 31
Dearborn 28
São Paulo 28
Dong Ket 26
Izmir 26
New York 25
Shanghai 25
Buffalo 24
Brussels 23
Phoenix 21
Dakar 19
Toronto 19
Düsseldorf 18
Guangzhou 18
Amsterdam 17
Da Nang 17
Milan 17
Orem 17
Lahore 16
Vienna 16
Chennai 15
Denver 15
Turku 15
Atlanta 14
Montreal 14
Genoa 13
Bern 12
Falls Church 12
Johannesburg 12
Stockholm 12
Haiphong 11
Manchester 11
Des Moines 10
Nuremberg 10
Paris 10
San Diego 10
San Francisco 10
Vancouver 10
Venezia 10
Boydton 9
Brooklyn 9
Hải Dương 9
Zhengzhou 9
Andover 8
Brno 8
Kunming 8
Mexico City 8
Portsmouth 8
Quito 8
Redondo Beach 8
Sydney 8
Thái Nguyên 8
Washington 8
Amman 7
Chongqing 7
Dongguan 7
Hillsboro 7
Nanjing 7
Riyadh 7
Totale 6.627
Salva come PNG Salva come JPEG
Nome #
DNA Nanotechnology for Cancer Therapy 591
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 497
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 473
Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia 422
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 362
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy 333
A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation. 310
Label-Free Quantification of Anticancer Drug Imatinib in Human Plasma with Surface Enhanced Raman Spectroscopy 275
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 272
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 270
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study 268
Peptide biosensors for anticancer drugs: Design in silico to work in denaturizing environment 266
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 255
Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical-Biomolecular Markers Significantly Associated With Toxicity 244
Development and validation of a selective SPR aptasensor for the detection of anticancer drug irinotecan in human plasma samples 240
Surface-enhanced Raman spectroscopy of the anti-cancer drug irinotecan in presence of human serum albumin 229
Common mutations in immunoglobulin VK3 light chain sequences from B-cells of HCV-related disorders 215
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 207
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 204
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: A first insight 203
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 199
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine 196
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target 193
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State 182
Differential proteomic analysis of hepatocellular carcinoma 181
Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy 174
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 168
Nanoparticles-based oligonucleotides delivery in cancer: Role of zebrafish as animal model 166
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients 161
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System 160
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 154
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 151
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 148
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies 146
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma 142
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells. 141
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs 137
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma 135
New insight into therapies targeting angiogenesis in hepatocellular carcinoma 134
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 132
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies 119
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS) 119
Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model 113
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma 108
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients 100
Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients 94
Oral Administration of Cancer Vaccines: Challenges and Future Perspectives 89
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies 82
Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer 78
Totale 10.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 62 25 72
2021/2022605 21 20 41 21 9 96 41 12 68 47 29 200
2022/20231.230 94 160 110 151 98 172 48 116 137 60 57 27
2023/2024647 38 35 36 56 45 67 102 151 7 19 60 31
2024/20251.722 39 52 96 146 145 169 139 124 202 223 216 171
2025/20263.382 451 133 357 351 350 292 513 111 399 425 0 0
Totale 10.238